Clinical Trials Directory

Trials / Completed

CompletedNCT05461443

Lacticaseibacillus Rhamnosus GG Pili Study

Study of the Modularity Immune Function of Lactobacillus Rhamnosus GG in the Small Intestine of Healthy Individuals

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Örebro University, Sweden · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study was to investigate the host-microbe interaction effects of various Lacticaseibacillus rhamnosus GG strains, with different binding capacities to the mucus in the small intestine, in healthy individuals

Detailed description

The project consisted in the supplementation of a) a wild-type LGG strain, b) a low-producing pili LGG strain or c) a high-producing pili LGG strain to study subjects. The individuals received the three treatment combinations in a randomised order. Each supplementation was given to the individuals every 30 min over a period of 6 hours. Eight biopsies from the duodenum were collected at the end of 6 h-solutions administration by flexible gastroduodenoscopy, likewise the routine procedure during this endoscopic investigation. Faecal samples were collected by the study subjects at home 1 day before, 2, 7 and 14 days days after administrations of each oral supplementation. The supplementations were separated by a 3-week wash-out period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic

Timeline

Start date
2016-03-31
Primary completion
2017-06-30
Completion
2017-06-30
First posted
2022-07-18
Last updated
2022-07-18

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05461443. Inclusion in this directory is not an endorsement.